DOCSLIB.ORG

Induction of Innate Immune Memory: the Role of Cellular Metabolism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Induction of Innate Immune Memory: the Role of Cellular Metabolism Available online at www.sciencedirect.com ScienceDirect Induction of innate immune memory: the role of cellular metabolism 1 1,2 Jorge Domı´nguez-Andre´ s , Leo AB Joosten and Mihai G Netea1,3,4 The paradigm that only adaptive immunity can develop providing effective and specific protection against re- immunological memory has recently been challenged by infection by the same microorganism [1]. The para- studies showing that cells from the innate immune system can digm of memory within the adaptive immune system is undergo functional reprogramming, facilitating a faster and essentially the result of somatic genetic re-arrange- enhanced response to secondary infections. This improved ments and clonal selection, while the innate immune secondary response is not always specific, as it can also system is a germline-encoded system that is not capa- protect from infections caused by non-related pathogens. This ble of carrying genetic memory through cell division. has been termed innate immune memory or trained As a result, innate immune system functions were immunity. Trained immunity not only involves rewiring the considered to be only associated with the nonspecific intracellular immune signaling of innate immune cells, but also acute elimination of pathogens either by cellular induces profound changes in cellular metabolic pathways such mechanisms such as phagocytosis, or humoral pro- as glycolysis, oxidative phosphorylation, fatty acid and amino cesses such as the complement system. However, in acid metabolism, increasing the capacity of the innate immune the last years, a series of discoveries have proven that cells to respond to a secondary stimulation. The understanding cells from the innate immune system are also able to of these intracellular processes opens new therapeutic undergo long-term adaptation and acquire enhanced possibilities for the modulation of the innate immune responses capability to respond to certain stimuli, a process that during infections and inflammatory diseases. has been termed innate immune memory or trained immunity [2], which is based on the long-term repro- Addresses gramming that the cells of the innate immune system 1 Department of Internal Medicine and Radboud Center for Infectious such as monocytes, macrophages and NK cells Diseases (RCI), Radboud University Nijmegen Medical Centre, Geert undergo after infection or vaccination [3]. This long- Grooteplein Zuid 8, 6525GA Nijmegen, The Netherlands term innate immune response does not have an anti- 2 Department of Medical Genetics, Iuliu Hatieganu University of Medicine gen-specific character, thus it does not rely on a par- and Pharmacy, 400349 Cluj-Napoca, Romania 3 ticular infectious organism or stimulant (Figure 1). For Department for Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany example, training with b-glucan, a component of fun- 4 Human Genomics Laboratory, Craiova University of Medicine and gal cell walls, induces increased protection against Pharmacy, Craiova, Romania bacterial infections caused by Staphylococcus aureus [4]. Similarly, muramyl dipeptide (MDP), a compo- Corresponding author: Netea, Mihai G ([email protected]) nent of bacterial cell wall peptidoglycan [5], can induce protection against toxoplasmosis, while CpG Current Opinion in Immunology 2019, 56:10–16 dinucleotides provide protection against Escherichia coli This review comes from a themed issue on Innate immunity infections [6]. Edited by Nicolas Manel and James Di Santo Furthermore, a growing body of evidence illustrates that For a complete overview see the Issue and the Editorial the development of trained immunity is not always ben- Available online 19th September 2018 eficial for the organism, and sterile inflammatory insults, https://doi.org/10.1016/j.coi.2018.09.001 such as oxLDL (oxidized low-density lipoprotein) and urate crystals can trigger strong proinflammatory 0952-7915/ã 2018 Elsevier Ltd. All rights reserved. responses that can potentially contribute to development of atherosclerosis or gout [7 ,8]. Increasing evidence links trained immunity to epigenetic and metabolic regulation that involve a number of central cellular metabolic path- ways such as glycolysis, oxidative phosphorylation Introduction (OXPHOS), glutaminolysis, as well as fatty acids and For a long time, it was thought that only adaptive cholesterol-synthesis pathways. In this review we will immunity had the ability to develop immunological focus on the most recent and relevant advances provide memory. Naive B and T lymphocytes first proliferate, novel insights into mechanisms centered on the immu- and then develop antigen-specific, long-lasting mem- nometabolic reprogramming that induces trained immu- ory cells after their first encounter with a pathogen, nity (Table 1). Current Opinion in Immunology 2019, 56:10–16 www.sciencedirect.com Metabolism in trained immunity Domı´nguez-Andre´ s, Joosten and Netea 11 Figure 1 Innate immune memory Adaptive immune memory Metabolic reprogramming Clonal expansion Epigenetic reprogramming Antigen-specificity Enhanced effector functions Generation of long-lasting memory cells Secondary response ‘Trained’ response to antigen Innate immune cells T and B cells Primary response to antigen First response antibody concentration strength of immune response time time First challenge Second challenge Initial exposure Secondary exposure to an antigen to the same antigen Current Opinion in Immunology Immunological memory is not exclusive of T and B lymphocytes. Cells from the innate immune system, such as monocytes, macrophages, DCs and NK cells are also influenced by the contact with different antigens, undergoing metabolic and epigenetic reprogramming and facilitating an enhanced response to future threats. While the responses driven by T and B lymphocytes are antigen-specific, secondary responses involving innate cells can be triggered by a wide variety of stimuli. Metabolic pathways in innate immune that is subsequently released from the cell, instead of memory entering the mitochondria to undergo oxidation [13]. Glycolysis Although less efficient in generating ATP than Aerobic respiration is the main source of ATP in most OXPHOS, glycolysis can be upregulated to a greater human cells. However, glycolysis, an alternative form of extent resulting in a faster production of ATP. As a result glucose metabolism, plays a central role in both immunity of this, innate immune cells can use this metabolic and disease states [9]. Several cell subsets require the adaptation to provide energy and building blocks needed upregulation of glycolysis during immune cell activation: for activation in a timely fashion. activated T cells show increased rates of glycolysis and so do proinflammatory macrophages [10,11], resulting in an Cheng et al. showed that glucose consumption is increased rate of glucose consumption with higher lactate increased in b-glucan-trained macrophages [14]. In a production [12]. After stimulation of macrophages, pyru- follow-up study, Arts et al. proved that glucose was con- vate produced from glucose is transformed into lactate verted into lactate in b-glucan-trained monocytes, vali- dating the upregulation of glycolysis with concomitant Table 1 lactate production in b-glucan-trained monocytes [15 ]. For its part, pro-inflammatory macrophages are highly Overview of pathologies in which a positive or a negative role for innate immune memory mechanisms have been reported glycolytic, but anti-inflammatory macrophages rely mainly on OXPHOS and fatty acid oxidation [16]. High Positive effects mediated by trained immunity-mediated mechanisms rates of glycolytic metabolism and the accumulation of Reversal of immunoparalysis in sepsis patients [44 ,48] intermediate metabolites of the TCA cycle such as fuma- Improved hematopoiesis under chemotherapy treatment [18 ] rate and succinate, control the methylation and acetyla- Non-specific protective effects of vaccinations [19,49] Protection from neonatal sepsis [43 ] tion of histones, forming the metabolic basis for trained immunity [15 ]. Several metabolites from glycolysis and the TCA cycle have been shown to act as cofactors for Negative effects mediated by trained immunity-mediated mechanisms DNA and histone methyltransferases and demethylases as well as histone acetyltransferases and deacetylases [17]. Atherosclerosis and systemic inflammation [32 ,47] Hyper immunoglobulin D syndrome [7 ] After priming of monocytes with b-glucan, genes Diabetes [45] involved in glycolysis, such as those encoding for the Alzheimer disease [46] rate-limiting enzymes of glucose metabolism hexokinase Autoimmune disorders Reviewed in Ref. [50] and pyruvate kinase, were epigenetically upregulated one week later [14]. This metabolic rewiring is also present in www.sciencedirect.com Current Opinion in Immunology 2019, 56:10–16 12 Innate immunity bone marrow progenitors, where b-glucan administration the accessibility to these genes for transcription factors involves a global increase in energy metabolism, being upon secondary stimulation. Acetylation of histones by glycolysis one of the most enriched pathways one week histone acetyl transferases (HATs) requires acetyl-CoA after b-glucan injection in mice [18 ]. Of note, the from the TCA cycle, which is supplied via the export of induction of glycolysis has recently been proven to be mitochondrial citrate [24]. Moreover, it has been shown crucial for the induction trained immunity following BCG that acetyl-CoA derived
Load more

Recommended publications
  • 2016: Immunometabolism
    Immunometabolism & 9, 2016 Paris, September 8 33è Journée Institut Cochin-JC Dreyfus & 7è Institut Cochin symposium, Paris (France) hursday, September 8, 2016 Metabolism and Immune cell Role of Immune cells in Diabetes and TFunction in Physiology and Cancer Atherosclerosis 09:00 Arginine and tryptophan metabolisms as team 14:30 players in immune regulation. Philippe Lesnik, Institute of Cardiometabolism and Ursula Grohmann, University of Perugia, Italy Nutrition (ICAN), Paris, France 09:30 Metabolism and survival of inflammatory cells. 15:00 Epigenomic control of macrophage activation in obesity Véronique Witko-Sarsat, Institut Cochin, Paris, and type 2 diabetes France Nicolas Venteclef, Centre de recherche des Cordeliers, Paris, France 10:00 T cell metabolism: it’s not all about glucose. Russell Jones, McGill University, Montreal, Canada 15:30 Coffee Break 10:30 Coffee Break 16:00 MAIT cells at the crossroad of microbiota, inflammation and diabetes. 11:00 Agnes Lehuen, Institut Cochin, Paris, France Olivier Hermine, Institut Imagine, Paris, France 16:30 Immunoregulation of liver fibrosis: novel targets. 11:30 The role of the hypoxic microenvironment in priming Sophie Lotersztajn, Centre de recherche sur immune response. l’inflammation CRI, Paris, France Randall Johnson, University of Cambridge, UK 17:00 Immune mechanisms of atherosclerosis. 12:00 Metabolism and T cell responses. Ziad Mallat, HEGP, Paris, France; King’s college, Christoph Hess, University Hospital Basel, Cambridge, UK Switzerland 17:30 Physiology of pro-inflammatory cytokines in metabolism: Therapeutic consequences. 12:30 Lunch Marc Donath, University Hospital Basel , Switzerland riday, September 9, 2016 Impact of Nutriments on Immune FCells at Steady state and Infection Keynote 09:00 Metabolic conditioning of hematopoietic stem 11:30 The birth of Immunometabolism and Implications for cell lineage specification: The Yins and Yangs of Metabolic Diseases.
    [Show full text]
  • PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/83292 Please be advised that this information was generated on 2017-12-06 and may be subject to change. De kunst van bruggen bouwen inaugurele rede door prof. dr. mihai g. netea inaugurele rede prof. dr. mihai g. netea In de afgelopen halve eeuw zijn we getuige geweest van een explosie in kennis over moleculaire biologie, cellu- laire fysiologie en genetica. Tegelijkertijd is er een steeds diepere kloof ontstaan tus- sen de onderzoeker en de klinisch specialist, en zijn de spectaculaire ontdekkin- gen gevolgd door een te- leurstellend gering aantal nieuwe geneesmiddelen. De uitdaging is om de bevin- dingen te vertalen naar de praktische klinische toe- passing. Volgens hoogleraar Experimentele interne genees- kunde Mihai Netea is het de taak van de translatione- le geneeskunde in het algemeen, en de experimentele interne geneeskunde in het bijzonder om een brug te bouwen tussen laboratorium en patiëntenzorg, met op die brug verkeer in beide richtingen. Hij richt zich enerzijds op de introductie van nieuwe geavanceerde technieken op het gebied van moleculaire biologie en celbiologie, en anderzijds op de versterking van trans- lationeel onderzoek tussen fundamentele wetenschap en klinisch onderzoek. Voor die versterking zijn inspanningen nodig van alle betrokkenen: nationale organisaties, universiteiten, onderzoeksgroepen en de onderzoekers zelf. Prof. dr. Mihai G. Netea (Cluj-Napoca, Roemenië, 1968) studeerde geneeskunde aan de Cluj-Napoca University, waar hij in 1993 afstudeerde. In 1998 pro- moveerde hij cum laude aan de Radboud Universiteit.
    [Show full text]
  • Chronic Tissue Inflammation and Metabolic Disease
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Chronic tissue inflammation and metabolic disease Yun Sok Lee and Jerrold Olefsky Department of Medicine, Division of Endocrinology and Metabolism, University of California at San Diego, La Jolla, California 92093, USA Obesity is the most common cause of insulin resistance, Although there are a number of potential, and some- and the current obesity epidemic is driving a parallel times overlapping, mechanisms that can contribute to in- rise in the incidence of T2DM. It is now widely recognized sulin resistance and β-cell dysfunction, in this current that chronic, subacute tissue inflammation is a major eti- review we focus on the role of chronic tissue inflamma- ologic component of the pathogenesis of insulin resis- tion in these metabolic defects. The reader is referred to tance and metabolic dysfunction in obesity. Here, we other excellent reviews on possible causes of insulin resis- summarize recent advances in our understanding of tance and β-cell dysfunction, independent of chronic tis- immunometabolism. We discuss the characteristics of sue inflammation (Halban et al. 2014; DeFronzo et al. chronic inflammation in the major metabolic tissues 2015; Czech 2017; Newgard 2017; Guilherme et al. and how obesity triggers these events, including a focus 2019; Kahn et al. 2019; Roden and Shulman 2019; Scherer on the role of adipose tissue hypoxia and macrophage-de- 2019; Alonge et al. 2021; Sangwung et al. 2020). rived exosomes. Last, we also review current and potential The interconnections between inflammation and meta- new therapeutic strategies based on immunomodulation.
    [Show full text]
  • Immunometabolism Research Focus: Cell Metabolism & NAD+ Metabolism
    www.adipogen.com Immunometabolism Research Focus: Cell Metabolism & NAD+ Metabolism Immunometabolism is a research field that provides new insights into the dynamic cross-talk between the immune system (immunity) and metabolic processes of an organism (metabolism). Immunometabolism tries to understand how metabolism controls the function of immune cells. It can be studied at a macroscopic level (e.g. in adipose tissues (see Figure 1) or in a tumor microenvironment) and at a microscopic level, the cellular bioenergetics of immune cells (see Figure 2). The activation, growth and proliferation, function and homeostasis of immune cells are intimately linked to dynamic changes in cellular metabolism configurations. The utilization of particular metabolic pathways is controlled by growth factors and nutrient availability (dictated by competition between other interacting cells) and by the balance of internal metabolites, reactive oxygen species (ROS) and reducing/oxidizing substrates. Major metabolic pathways (see Figure 2) that shape the immune cell response include glycolysis, the tricarboxylic acid (TCA) cycle, the pentose phosphate pathway (PPP), fatty acid oxidation (FAO), fatty acid synthesis (FAS) and amino acid (AA) metabolism (e.g. Glutamine, Arginine, Tryptophan). The various immune cell subsets use distinct metabolic pathways to promote cell survival, lineage generation and function. For example, inflammatory M1 macrophages or rapidly proliferating effector T cells, including T helper 1 (TH1), TH17 and cytotoxic CD8+ T cells, use metabolic pathways that support cell proliferation and the production of cytokines, such as glycolysis or fatty acid synthesis. M2 macrophages or immunosuppressive regulatory T (Treg) cells use metabolic pathways which inhibit inflammatory signals and are associated with suppressive functions, such as TCA cycle and fatty acid oxidation.
    [Show full text]
  • Neue Arbeitsgruppe Am LIMES-Institut: Infectious Deseases and Global Health Interview Mit Prof. Dr. Mihai Netea 12. Januar 2017
    Neue Arbeitsgruppe am LIMES-Institut: Infectious deseases and global health Interview mit Prof. Dr. Mihai Netea 12. Januar 2017 Since January 2017, Prof. Dr. Mihai Netea has a new working group at the LIMES Institute. He will be em- ployed both at the University of Nijmegen and the University of Bonn. To get to know him a bit, we asked him a few questions: Welcome to the LIMES team. Please introduce your- self in a few sentences. I am an internist and infectious diseases specialist. I was born and did my medical studies in Cluj-Napoca, ning of building a research culture, but this has started Romania. After finishing the medical studies in 1993, I to change fast in the last couple of years. moved to Radboud University Nijmegen for the PhD and clinical specialization with the group of Prof. Dr. What inspired your decision to join the LIMES Insti- Jos van der Meer. After another year as a post-doc at tute in Bonn? the University of Colorado, Denver, in the lab of Prof. Charles Dinarello, I moved back to Nijmegen, where I have had a very fruitful collaboration with researchers I work as a Professor of Experimental Medicine since at LIMES for several years already. It was very stimula- 2008. ting to perform these collaborative projects together, and we have observed how nice our expertise is com- You are working on infectious diseases and global plementary. It was thus an organic process in which health. What is your key interest and why? we thought to improve this collaboration even further by joining the LIMES.
    [Show full text]
  • Immunometabolism in Type 2 Diabetes Mellitus: Tissue-Specific Interactions
    State of the art paper Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions Erika Pinheiro-Machado1, Ewa Gurgul-Convey2, Michal T. Marzec3 1University Medical Center Groningen, Department of Pathology and Medical Biology, Corresponding author: Netherlands Assoc. Prof. Michal T. Marzec 2Institute of Clinical Biochemistry, Hannover Medical School, Germany University of Copenhagen 3Department of Biomedical Sciences, University of Copenhagen, Denmark Department of Biomedical Sciences Submitted: 14 August 2019 Panum Institute, room 12.6.10 Accepted: 23 October 2019 Blegdamsvej 3 DK-2200 Copenhagen N Arch Med Sci Denmark DOI: https://doi.org/10.5114/aoms.2020.92674 E-mail: [email protected] Copyright © 2020 Termedia & Banach Abstract The immune system is frequently described in the context of its protective function against infections and its role in the development of autoimmuni- ty. For more than a decade, the interactions between the immune system and metabolic processes have been reported, in effect creating a new re- search field, termed immunometabolism. Accumulating evidence supports the hypo thesis that the development of metabolic diseases may be linked to inflammation, and reflects, in some cases, the activation of immune responses. As such, immunometabolism is defined by 1) inflammation as a driver of disease development and/or 2) metabolic processes stimulating cellular differentiation of the immune components. In this review, the main factors capable of altering the immuno-metabolic communication leading to the development and establishment of obesity and diabetes are compre- hensively presented. Tissue-specific immune responses suggested to impair metabolic processes are described, with an emphasis on the adipose tissue, gut, muscle, liver, and pancreas.
    [Show full text]
  • Pathogens Hijack Host Cell Metabolism: Intracellular Infection As a Driver of the Warburg Effect in Cancer and Other Chronic Inflammatory Conditions
    ij.hapres.com Review Pathogens Hijack Host Cell Metabolism: Intracellular Infection as a Driver of the Warburg Effect in Cancer and Other Chronic Inflammatory Conditions Amy D. Proal 1, Michael B. VanElzakker 1,2,* 1 PolyBio Research Foundation, Kenmore, WA 98028, USA 2 Division of Neurotherapeutics, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA * Correspondence: Michael B. VanElzakker, Email: [email protected]. ABSTRACT The Warburg effect refers to a metabolic state in which cells preferentially use aerobic glycolysis rather than oxidative phosphorylation to generate ATP and macromolecules. A number of chronic inflammatory conditions are characterized by host cells that adopt a sustained, pathological Warburg-like metabolism. In cancer, previously healthy cells shift into a Warburg state centered on rapid energy production and increased cell proliferation that drives tumor formation. Macrophage in atherosclerotic plaque and in sarcoidosis granuloma can also harbor a Warburg-like phenotype that promotes an inflammatory milieu. The question of why host cells in patients with cancer and other chronic inflammatory conditions adapt a pathological Warburg-like metabolism is a matter of debate. This review/hypothesis piece explores how intracellular infection can contribute to this Warburg metabolism or related pathological metabolic states. We detail molecular mechanisms by which viral, bacterial, and protozoan intracellular pathogens can induce, or contribute to, a Warburg-like metabolism in infected host cells in order to meet their own replication and nutritional needs. We also discuss how host defense Open Access towards infection may impact cellular metabolic changes. We then provide examples of how many of these same intracellular pathogens Received: 01 September 2020 have been identified in tumors, atherosclerotic lesions, granuloma, and Accepted: 08 December 2020 other tissues containing cells with a Warburg or altered metabolism.
    [Show full text]
  • Defining Trained Immunity and Its Role in Health and Disease
    REVIEWS Defining trained immunity and its role in health and disease Mihai G. Netea 1,2,3 ✉ , Jorge Domínguez- Andrés1,2, Luis B. Barreiro4,5,6, Triantafyllos Chavakis7,8, Maziar Divangahi9,10,11, Elaine Fuchs12, Leo A. B. Joosten1,2, Jos W. M. van der Meer1,2, Musa M. Mhlanga13,14, Willem J. M. Mulder15,16,17, Niels P. Riksen1,2, Andreas Schlitzer18, Joachim L. Schultze3, Christine Stabell Benn19, Joseph C. Sun20,21,22, Ramnik J. Xavier23,24 and Eicke Latz25,26,27 ✉ Abstract | Immune memory is a defining feature of the acquired immune system, but activation of the innate immune system can also result in enhanced responsiveness to subsequent triggers. This process has been termed ‘trained immunity’, a de facto innate immune memory. Research in the past decade has pointed to the broad benefits of trained immunity for host defence but has also suggested potentially detrimental outcomes in immune-mediated and chronic inflammatory diseases. Here we define ‘trained immunity’ as a biological process and discuss the innate stimuli and the epigenetic and metabolic reprogramming events that shape the induction of trained immunity. Pattern recognition The vertebrate immune system has traditionally been called ‘LPS tolerance’, which can be induced by low receptors divided into innate and adaptive arms. Cells of the innate doses of lipopolysaccharide (LPS) and other Toll-like (PRRs). Germline- encoded immune system recognize pathogens and tissue damage receptor ligands, is also an adaptation of cellular receptors that recognize through germline- encoded pattern recognition receptors responses to an external stimulus, but which leads to a pathogen-associated molecular (PRRs)1,2, which sense diverse pathogen- associated lower inflammatory response to a second stimulation13.
    [Show full text]
  • Skeletal Muscle Immunometabolism in Women with Polycystic Ovary Syndrome: a Meta-Analysis
    SYSTEMATIC REVIEW published: 22 October 2020 doi: 10.3389/fphys.2020.573505 Skeletal Muscle Immunometabolism in Women With Polycystic Ovary Syndrome: A Meta-Analysis Maria Manti 1†, Elisabet Stener-Victorin 1† and Anna Benrick 2,3*† 1 Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 2 Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 3 School of Health Sciences, University of Skövde, Skövde, Sweden Edited by: Arthur J. Cheng, York University, Canada Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder affecting Reviewed by: up to 15% of women at reproductive age. The main features of PCOS are Danielle Hiam, Victoria University, Australia hyperandrogenism and irregular menstrual cycles together with metabolic dysfunctions Robert W. Wiseman, including hyperinsulinemia and insulin resistance and a 4-fold increased risk of developing Michigan State University, United States type 2 diabetes. Despite the high prevalence the pathophysiology of the syndrome *Correspondence: is unclear. Insulin resistance in women with PCOS likely affect the skeletal muscle Anna Benrick and recently it was demonstrated that changes in DNA methylation affects the gene [email protected] expression in skeletal muscle that in part can explain their metabolic abnormalities. †ORCID: The objective of this work was to combine gene expression array data from different Maria Manti datasets to improve statistical power and thereby identify novel biomarkers that can orcid.org/0000-0003-4370-4780 Elisabet Stener-Victorin be further explored. In this narrative review, we performed a meta-analysis of skeletal orcid.org/0000-0002-3424-1502 muscle arrays available from Gene Expression Omnibus and from publications.
    [Show full text]
  • De Novo Lipogenesis Products and Endogenous Lipokines
    Diabetes 1 Mustafa Yilmaz,1 Kathryn C. Claiborn,1 and Gökhan S. Hotamisligil1,2 De Novo Lipogenesis Products and Endogenous Lipokines DOI: 10.2337/db16-0251 Recent studies have shown that in addition to their major lipid metabolism pathways that support DNL and traditionally recognized functions as building blocks, their bioactive products with identified roles in metabolic energy stores, or hazardous intermediates, lipids also disease. Further research in these areas may highlight novel have the ability to act as signaling molecules with endocrine pathways and translational opportunities. potent effects on systemic metabolism and metabolic diseases. This Perspective highlights this somewhat REGULATION OF DNL less apparent biology of lipids, especially focusing on De novo synthesis of fatty acids takes place primarily in de novo lipogenesis as a process that gives rise to key DIABETES messenger molecules mediating interorgan communi- the liver (2). Under physiological conditions, excess car- cation. Elucidating the mechanisms of lipid-dependent bohydrates that are not stored as glycogen in hepatocytes coordination of metabolism promises invaluable insights are converted into fatty acids and esterified into triglyc- into the understanding of metabolic diseases and may erides. Dysregulation of DNL and other aspects of lipid contribute to the development of a new generation of metabolism are common features of obesity and obesity- SYMPOSIUM preventative and therapeutic approaches. associated metabolic diseases such as insulin resistance and diabetes. In the liver, obesity causes increased DNL activity and fatty acid esterification, which may be a con- Lipids have long been known for their roles in cellular tributing factor to local and systemic metabolic deteriora- structure and energy storage.
    [Show full text]
  • Lecture Series TWINCORE, SEMINAR ROOM Ground Floor
    October 10, 2019 | 16:00 Lecture Series TWINCORE, SEMINAR ROOM Ground Floor Trained immunity: a memory for innate host defense Prof. Dr. Mihai G. Netea, Radbound University Medical Center Mihai Netea was born and studied medicine in Cluj-Napoca, Romania. He completed his PhD at the Radboud University Nijmegen,The Netherlands, on studies investigating the cytokine network in sepsis. After working as a post-doc at the University of Colorado, he returned to Nijmegen where he finished his clinical training as an infectious diseases specialist, and where he currently heads the division of Experimental Medicine, Department of Internal Medicine, Nijmegen University Nijmegen Medical Center. He is mainly interested in understanding the factors influencing variability of human immune responses, the biology of sepsis and immunoparalysis in bacterial and fungal infections, and the study of the memory traits of innate immunity. He is the recipient of the Spinoza Prize 2016, and an ERC Advanced grant in 2019. Urate Induced Epigenetic Reprogramming in Myeloid cells Prof. Dr. Leo Joosten, Radbound University Medical Center Leo Joosten was born Gendt and studied pathobiology in Nijmegen, The Netherlands. He completed his PhD at the Radboud UniversityNijmegen, The Netherlands. He explored the cytokine networks in rheumatoid arthritis and how to target IL-1 in this destructive disorder. Currently, Joosten is head the Research Laboratory of Experimental Medicine, Department of Internal Medicine, Nijmegen University Nijmegen Medical Center. He is mainly interested in the pathophysiology of inflammation, with focus on gout and Lyme arthritis, and the role of IL-1 family members in these joint diseases. He is director of HINT project at Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania and adjunct professor at University of Alabama Birmingham, Birmingham, USA.
    [Show full text]
  • Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression
    cancers Review Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression Remya Raja 1,†, Christopher Wu 1,†, Francesca Limbeck 1, Kristina Butler 2, Abhinav P. Acharya 3 and Marion Curtis 1,4,5,* 1 Department of Immunology, Mayo Clinic, Scottsdale, AZ 85259, USA; [email protected] (R.R.); [email protected] (C.W.); [email protected] (F.L.) 2 Division of Gynecologic Surgery, Mayo Clinic, Phoenix, AZ 85054, USA; [email protected] 3 Department of Chemical Engineering, School for the Engineering of Matter, Transport and Energy, Arizona State University, Tempe, AZ 85281, USA; [email protected] 4 Department of Cancer Biology, Mayo Clinic, Scottsdale, AZ 85259, USA 5 College of Medicine and Science, Mayo Clinic, Scottsdale, AZ 85259, USA * Correspondence: [email protected] † These authors contributed equally to this work. Simple Summary: Metabolism is the process by which living organisms and cells generate energy to sustain life. At the organismal level, metabolic homeostasis is a tightly controlled balance between energy consumption and energy expenditure. Many studies have shown that disruption of this homeostasis leads to an inflammatory phenotype within adipose tissue. The aim of this review is to provide an overview of the dynamic metabolic interplay within adipose tissue and its implications for cancer progression and metastasis. Abstract: Disruption of metabolic homeostasis at the organismal level can cause metabolic syndrome associated with obesity. The role of adipose tissue in cancer has been investigated over the last Citation: Raja, R.; Wu, C.; Limbeck, several decades with many studies implicating obesity as a risk factor for the development of F.; Butler, K.; Acharya, A.P.; Curtis, M.
    [Show full text]